Mifepristone
A to Z Drug Facts
Mifepristone |
Mifeprex |
Class: Abortifacient |
Action Competes with progesterone at progesterone-receptor sites.
Indications Termination of pregnancy through day 49 of pregnancy. Unlabeled use(s): Postcoital contraception; intrauterine fetal death/nonviable early pregnancy; unresectable meningioma; endometriosis; Cushing syndrome.
Contraindications Confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass; UD in place; chronic adrenal failure; concurrent long-term corticosteroid therapy; history of allergy to mifepristone, misoprostol, or other prostaglandin; emorrhagic disorders or concurrent anticoagulant therapy; inherited porphyrias.
ADULT: PO Day 1: Patient takes 600 mg mifepristone in a single dose. Day 3: Unless a confirmed abortion has occurred, patient takes 400 mcg misoprostol. Day 14: Follow-up visit to confirm by clinical examination or ultrasonographic scan that a complete termination of pregnancy has occurred.
Erythromycin, grapefruit juice, itraconazole, ketoconazole: May increase mifepristone plasma levels. Carbamazepine, dexamethasone, phenobarbital, phenytoin, rifampin, St. John's wort: May decrease mifepristone plasma levels.
Lab Test Interferences None well documented.
CNS: Headache; dizziness; insomnia; anxiety; syncope; fainting. EENT: Sinusitis. GI: Abdominal pain and cramping; nausea; vomiting; diarrhea; dyspepsia. GU: Uterine cramping and hemorrhage; vaginitis; pelvic pain. HEMA: Anemia; decreased hemoglobin. OTHER: Fatigue; back pain; fever; viral infections; rigors; chills; shaking; sthenia; leg pain; leukorrhea.
Pregnancy: Indicated for termination of pregnancy. Lactation: Undetermined. Children: Safety and efficacy not established. Elderly: Safety and efficacy not established. Monitoring: Qualified physician must supervise administration. Surgical intervention: Facilities for transfusions and resuscitation may be necessary in incomplete abortion. Vaginal bleeding: Occurs in almost all patients. Availability: Available only through selected physician offices.
PATIENT CARE CONSIDERATIONS |
|
|
Books@Ovid
Copyright © 2003 Facts and Comparisons
David S. Tatro
A to Z Drug Facts